Archive for June 2015

Discovery of Cellular Mechanism of Action of tACPA in Rheumatoid Arthritis

Citryll B.V. founded to accelerate tACPA development June 11, 2015 – Oss, The Netherlands. ModiQuest B.V., a Dutch antibody drug development and diagnostics company focused on chronic inflammatory diseases, today announces that it has discovered the cellular mechanism of action of its therapeutic anti-citrullinated protein lead antibodies (tACPA) for the treatment of rheumatoid arthritis (RA) … Continue reading

ModiQuest – at US BIO International Convention, Philadelphia, June 15-18, 2015

Looking for additional outsourcing options for generating antibodies against priority or difficult target antigens? Or is your in-house capacity to generate antibodies running short? Pass by our booth at the event and talk to us about your antibody needs! Or call us on +31 412 846 000 to fix a time to talk! About ModiQuest … Continue reading

ModiQuest – at Next-Generation Antibodies and Protein Analysis conference in Gent, Belgium, June 15-16, 2015

Looking for additional outsourcing options for generating antibodies against priority or difficult target antigens? Or is your in-house capacity to generate antibodies running short? Pass by our booth at the event and talk to us about your antibody needs! Or call us on +31 412 846 000 to fix a time to talk! About ModiQuest … Continue reading

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop